drugset
drugset / Trial / NCT02083406

Bioavailability Study of Oral OZ439 Prototype Formulations Administered With Piperaquine Phosphate (PQP)

NCT02083406 ↗

Phase 1 Completed 22 enrolled Medicines for Malaria Venture Quotient Clinical · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

A single dose study to investigate how different formulations of OZ439 co-administered with PQP tablest are processed by the body when taken without food

Timeline

Start
2014-07
Primary completion
2014-07
Completion
2014-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Artefenomel Small molecule 800 mg Oral
Background piperaquine Small molecule 960 mg —

Indications

malaria